Twenty years after the release of the human genome, the genetic “blueprint” of human life, an international research team, including the University of British Columbia’s Chris Overall, has now mapped the first draft sequence of the human proteome.
Category: biotech/medical – Page 119
Mitochondrial checkpoint enables dendritic cells to activate T lymphocytes against viruses, tumors
A study led by researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has identified a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors. Dendritic cells are immune cells that detect threats and activate the body’s defenses, acting as “sentinels” that instruct T lymphocytes on what to attack.
The study, published in Science Immunology, shows that restoring the internal chemical imbalance caused by defective mitochondrial function in dendritic cells restores the capacity of immune cells to defend the body against infection. The findings could open new avenues for improving cancer immunotherapy.
The study reveals that the ability of dendritic cells to activate T lymphocytes depends on an unexpected mechanism: the proper functioning of mitochondrial complex I, a key mitochondrial component. Mitochondrial complex I acts as a “metabolic switch” that is essential for the ability of dendritic cells to convert viral or tumor-derived material into effective immune activation signals and trigger a strong T-cell response.
Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management
Renal oncocytic neoplasms present diagnostic challenges, both at imaging and pathologic evaluation. The World Health Organization classification of renal neoplasms defines a spectrum of oncocytic neoplasms, including emerging entities that help define previously uncharacterized or mischaracterized tumors. Low-grade oncocytic tumors and eosinophilic vacuolated tumors are distinguishable from other oncocytic neoplasms at pathologic evaluation and typically demonstrate indolent behavior. Nomenclature regarding hybrid neoplasms has been clarified in reference to hereditary cases associated with Birt-Hogg-Dubé syndrome. Preoperative diagnostic difficulties at imaging contribute to high rates of resected benign renal tumors, the majority being renal oncocytomas. The imaging appearances of oncocytic neoplasms are similar, and the inability to confidently diagnose them at imaging has led to increased resection rates. Preoperative renal mass biopsy may be preventative, but its utilization remains low, diagnoses can be equivocal, and establishing tumor aggressiveness may not always be reliable. Malignant renal oncocytic tumors, including chromophobe renal cell carcinoma, are generally considered the less aggressive subtypes of renal cell carcinoma. However, distinguishing them from the more aggressive clear cell subtype remains challenging, despite imaging frameworks designed to aid categorization. Active surveillance is a safe management option among biopsy-confirmed renal oncocytic neoplasms, but it remains uncertain which patients are suitable for this approach. Diagnostic imaging may assist in risk-stratifying oncocytic neoplasms, with mass enhancement, heterogeneity, and calcification potentially differentiating benign from malignant oncocytic neoplasms. Mass attenuation and heterogeneity may differentiate low-grade and high-grade cancers. Molecular imaging and other emerging techniques, such as MR fingerprinting, may play a role in the future.
©RSNA, 2026
Supplemental material is available for this article.
Surprising cellular dynamics of the aging brain
Scheidemantel et al. address the complexity of Alzheimer’s disease by integrating comprehensive multi-omics data from over 1,300 aged individuals, revealing coordinated molecular mechanisms across brain systems. The findings provide crucial insights into age-related traits and disease pathways, paving the way for potential therapeutic strategies.
Capsida’s Trailblazing Moment: What the Field Owes the Next BBB Program
An insightful perspective on what biological factors may have been the cause of a patient’s death after receiving a blood-brain-barrier crossing AAV treatment. It’s crucial for the field to think about this carefully as we move forward.
Brief disclosure: I am a named inventor on patents and author on publications related to AAV capsid engineering and CNS gene delivery, developed during my time at the Broad Institute. I now operate independently. This post does not represent any prior employer, current advisory client, or collaborator. The mechanistic analysis presented here is my own scientific interpretation of publicly available data. Full disclosures at the bottom.
Mitochondria as sources and targets of cellular signaling
Meichsner et al. review recent insights into mitochondria as dynamic signaling hubs. The authors describe how structural plasticity and interorganellar communication enable mitochondria to serve as both sources and targets of signaling, coordinating stress responses, metabolic adaptation, and innate immune pathways to safeguard cellular homeostasis.
The Scientist Who Plans To End Aging Forever — Aubrey de Grey
Aubrey de Grey believes aging isn’t inevitable — it’s a solvable engineering problem. In this conversation, we explore why society treats aging as untouchable, how “longevity escape velocity” could allow us to live indefinitely, and why reversing damage—not slowing it—is the future of medicine. He breaks down how our medical system profits from sickness, and how progress is slowed by fear and outdated norms. The end of aging as we know it is coming and it’s happening faster than you think. #preventativehealth #preventativecare #aging #health #medicine.
Connect With Me: / tim.doy1e.
Timestamps:
00:00 How We Understand Aging.
06:01 How Aubrey Found His Work.
10:42 Longevity Escape Velocity.
12:45 Not Being Controlled.
15:11 Investor-Humanitarian Structure.
16:51 Balancing Work With Publicity.
17:26 Aubrey’s Current Work.
27:36 Getting Pushback & The Medical System.
33:11 Shifting To Preventative Care.
36:14 What Has & Hasn’t Changed.
41:52 Consciousness & Aging.
46:00 How To Popularize Ideas.
48:10 The Future Of Aubrey’s Work.
50:58 Connect With Aubrey de Grey.
From whole-body to organ-specific biological age clocks
Zalesky and colleagues discuss the evolution of aging clocks into organ-specific aging readouts that harness omics and imaging data. They review the insights that this additional resolution provides on differential aging across organs within interconnected systems, as well as the methods, priorities and future directions.